The Latest Breaking News from Pablo Zuanic

These Are The Top Cannabis Stock Picks According To 3 Of The Top Equity Analysts In The Marijuana Market

What are the best cannabis stocks to invest in right now?

Benzinga · Jul 19, 2022

OrganiGram Beat Fact Set Expectations: "The Stock Represents Good Value," Analyst Says

On Thursday, Organigram Holdings Inc. (OGI.TO) (NASDAQ: OGI), a cannabis company focused on producing high-quality, indoor-grown cannabis for patients and adult recreational consumers in Canada,

Benzinga · Jul 14, 2022

Medical Marijuana Sales In US Plunge As Recreational Biz Bounces Back, Analyst Opines On Ways To Build Market Resilience

Federal legalization of cannabis seems to be moving slowly. However, states are lifting their bans on both medical and recreational marijuana one by one.

Benzinga · Jul 13, 2022

Is A Compromise On The Horizon? Why Schumer Might Act On Cannabis Banking Sooner Rather Than Later

The Senate has been under pressure from all sides recently to pass the SAFE Banking Act that would "help cannabis-related businesses, support innovation, create jobs, and strengthen public safety in our com

Benzinga · Jun 10, 2022

Top Cannabis Companies By Revenue In May, Marijuana Stocks To Check Out As Earnings Season Fades

As another earnings season draws to a close, investors in cannabis stocks have gone through some trying times.

Benzinga · Jun 1, 2022

After A Challenging March Quarter Canopy Growth Projects Positive EBITDA By FY 2024

Pablo Zuanic from Cantor Fitzgerald kept a rating of “Neutral” for the stocks of Canopy Growth Corp. (TSE: WEED) (NASDAQ: CGC) and lowered his 12-month price target to C$6.75 from C$7.75 due to the sectoral derating and red

Benzinga · May 27, 2022

Analyst Says New Jersey Rec Marijuana Market Holds High Potential Despite Slow Start, Here's Why

New Jerseyans spent $24 million on weed during the first month of recreational sales, roughly $5 million a week after a record-breaking first day when

Benzinga · May 27, 2022

AYR Wellness: Management Expects 'Significant Sales' And 'EBITDA Ramp' In 2022

The Analyst Pablo Zuanic from Cantor Fitzgerald kept a rating of "Neutral" on Ayr Wellness Inc. (OTC: AYRWF) stocks and lowered its 12-month price target to $6.75 from $13.30, due to reduced estimates and overall sectoral derating.

Benzinga · May 26, 2022

Cannabis Reform Is 'By Far The Main Catalyst,' Analyst Discusses Jushi's Q4 Financial Results

Jushi Holdings Inc. (OTCQX: JUSHF) (CSE:JUSH) released its financial results for the first quarter of 2022 ended March 31, 2022, revealing revenue of $61

Benzinga · May 26, 2022

Jim Cramer Explains What Needs To Happen For Cannabis Stocks To Bounce Back

Cannabis investors are in the midst of earnings season, which is also a timely opportunity to take a glimpse at the stock performance of some big players within the space.

Benzinga · May 23, 2022